Behavioral Voluntary and Social Bioassays Enabling Identification of Complex and Sex-Dependent Pain-(-Related) Phenotypes in Rats with Bone Cancer.
bone cancer
home cage
pain
rodent-specific behavior
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
02 Mar 2023
02 Mar 2023
Historique:
received:
22
12
2022
revised:
06
02
2023
accepted:
28
02
2023
entrez:
11
3
2023
pubmed:
12
3
2023
medline:
12
3
2023
Statut:
epublish
Résumé
Cancer-induced bone pain (CIBP) is a common and devastating symptom with limited treatment options in patients, significantly affecting their quality of life. The use of rodent models is the most common approach to uncovering the mechanisms underlying CIBP; however, the translation of results to the clinic may be hindered because the assessment of pain-related behavior is often based exclusively on reflexive-based methods, which are only partially indicative of relevant pain in patients. To improve the accuracy and strength of the preclinical, experimental model of CIBP in rodents, we used a battery of multimodal behavioral tests that were also aimed at identifying rodent-specific behavioral components by using a home-cage monitoring assay (HCM). Rats of all sexes received an injection with either heat-deactivated (sham-group) or potent mammary gland carcinoma Walker 256 cells into the tibia. By integrating multimodal datasets, we assessed pain-related behavioral trajectories of the CIBP-phenotype, including evoked and non-evoked based assays and HCM. Using principal component analysis (PCA), we discovered sex-specific differences in establishing the CIBP-phenotype, which occurred earlier (and differently) in males. Additionally, HCM phenotyping revealed the occurrence of sensory-affective states manifested by mechanical hypersensitivity in sham when housed with a tumor-bearing cagemate (CIBP) of the same sex. This multimodal battery allows for an in-depth characterization of the CIBP-phenotype under social aspects in rats. The detailed, sex-specific, and rat-specific social phenotyping of CIBP enabled by PCA provides the basis for mechanism-driven studies to ensure robustness and generalizability of results and provide information for targeted drug development in the future.
Identifiants
pubmed: 36900357
pii: cancers15051565
doi: 10.3390/cancers15051565
pmc: PMC10000428
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : EU, ERANETLAC
ID : ELAC2015/T07-0713, #443180/2016-4, #309633/2021-4
Références
Science. 2021 Jan 8;371(6525):153-159
pubmed: 33414216
Cell Tissue Bank. 2004;5(4):205-12
pubmed: 15591823
J Proteome Res. 2021 Dec 3;20(12):5241-5263
pubmed: 34672606
PLoS Biol. 2020 Jul 14;18(7):e3000410
pubmed: 32663219
Neurosci Biobehav Rev. 1999 Nov;23(7):1029-36
pubmed: 10580315
Pain. 2021 Aug 1;162(8):2186-2200
pubmed: 34256379
Harv Rev Psychiatry. 2015 Jul-Aug;23(4):263-87
pubmed: 26062169
Neurosci Biobehav Rev. 2020 Jun;113:238-261
pubmed: 32147529
PLoS Biol. 2022 May 5;20(5):e3001564
pubmed: 35511779
PLoS One. 2012;7(4):e35656
pubmed: 22558191
J Neuroinflammation. 2012 Dec 26;9:278
pubmed: 23268791
Mol Pain. 2020 Jan-Dec;16:1744806920919568
pubmed: 32349612
Neurosci Biobehav Rev. 2011 Oct;35(9):1864-75
pubmed: 21672550
J Pain. 2016 Sep;17(9 Suppl):T21-49
pubmed: 27586830
Eur J Pain. 2021 Apr;25(4):731-756
pubmed: 33625769
Front Pharmacol. 2016 Aug 31;7:286
pubmed: 27630567
Cancer Cell Int. 2013 Feb 01;13(1):5
pubmed: 23374226
J Mol Neurosci. 2014 Apr;52(4):566-76
pubmed: 24057889
Mol Pain. 2016 Jun 15;12:
pubmed: 27306409
Am J Ment Defic. 1981 Sep;86(2):127-37
pubmed: 7315877
Neuron. 2021 Sep 1;109(17):2641-2642
pubmed: 34473950
Nat Methods. 2014 Jun;11(6):629-32
pubmed: 24776635
Med Oncol. 2021 Sep 28;38(11):134
pubmed: 34581894
Neurosci Biobehav Rev. 1997 May;21(3):309-26
pubmed: 9168267
Med Clin North Am. 2016 Jan;100(1):55-64
pubmed: 26614719
Pain. 2015 Apr;156 Suppl 1:S35-S41
pubmed: 25789435
Pain. 2018 Sep;159(9):1752-1763
pubmed: 29927790
Mol Neurobiol. 2020 Jan;57(1):41-50
pubmed: 31494825
Eur J Neurosci. 2014 Jun;39(11):1881-90
pubmed: 24888508
Curr Top Behav Neurosci. 2014;20:233-50
pubmed: 24557935
PLoS One. 2017 Apr 5;12(4):e0175258
pubmed: 28380075
Sci Adv. 2016 Oct 19;2(10):e1600855
pubmed: 27774512
Pain. 1983 Jun;16(2):109-110
pubmed: 6877845
Pain. 2021 Jul 1;162(7):2070-2086
pubmed: 33492035
Neurosci Bull. 2018 Feb;34(1):216-236
pubmed: 28493169
Front Pharmacol. 2017 Jul 06;8:442
pubmed: 28729837
Nature. 2019 Mar;567(7749):448-450
pubmed: 30918396
J Pain. 2011 Jun;12(6):698-711
pubmed: 21497141
Pain. 2014 Jul;155(7):1253-1261
pubmed: 24699208
Nat Rev Neurosci. 2022 Feb;23(2):70-85
pubmed: 34837072
Physiol Behav. 2021 Jan 1;228:113220
pubmed: 33122091
J Neurosci. 2006 Jan 25;26(4):1281-92
pubmed: 16436616
Pain. 1988 Jan;32(1):77-88
pubmed: 3340425
Pain. 2016 Apr;157(4):788-790
pubmed: 26683235
Br J Pharmacol. 2014 Jun;171(12):2951-63
pubmed: 24527763
J Neurosci Methods. 2007 Jun 15;163(1):9-16
pubmed: 17382401
Front Behav Neurosci. 2018 Oct 17;12:242
pubmed: 30386220
PLoS One. 2010 Oct 29;5(10):e13774
pubmed: 21048940
Front Immunol. 2020 Jul 29;11:1652
pubmed: 32849569
J Neurosci. 2011 Oct 26;31(43):15450-4
pubmed: 22031891
Behav Brain Res. 2018 Jan 15;336:261-268
pubmed: 28842269
Front Pain Res (Lausanne). 2021 Sep 10;2:735838
pubmed: 35295496
MMWR Recomm Rep. 2016 Mar 18;65(1):1-49
pubmed: 26987082
Pain. 2019 Jan;160(1):38-44
pubmed: 30586069
Pain. 2013 Jun;154(6):917-26
pubmed: 23582155
Neurosci Biobehav Rev. 1988 Summer;12(2):123-37
pubmed: 3050629
Int J Mol Sci. 2019 Nov 30;20(23):
pubmed: 31801267
Eur J Cancer. 2008 May;44(8):1083-90
pubmed: 18439817
Cells. 2021 Nov 23;10(12):
pubmed: 34943780
Neuroscience. 2000;98(3):585-98
pubmed: 10869852
Front Mol Neurosci. 2017 Sep 06;10:284
pubmed: 28932184
Lab Anim. 2020 Apr;54(2):150-158
pubmed: 32050843
J Pain. 2008 Oct;9(10):945-54
pubmed: 18650131
Nat Methods. 2012 Jul;9(7):671-5
pubmed: 22930834
Cell Rep. 2021 Dec 21;37(12):110152
pubmed: 34936870
Neurosci Biobehav Rev. 2019 May;100:335-343
pubmed: 30885811